Characterization of two hepatitis B virus populations isolated from a hepatitis B surface antigen-negative patient

Hepatology

Volumn 35, Issue 5, 2002, Pages 1215-1224

  Jeantet, Damien ^a   Chemin, Isabelle ^a   Mandrand, Bernard ^b   Zoulim, Fabien ^a,c   Trepo, Christian ^a,c   Kay, Alan ^a  

^a INSERM   (France)

^b UNIVERSITÉ DE LYON   (France)

^c Service d'Hepato Gastroenterologie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

AGED; ARTICLE; CASE REPORT; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MALE; PRIORITY JOURNAL; PROMOTER REGION; TATA BOX; VIRUS GENOME; VIRUS IDENTIFICATION; VIRUS ISOLATION; VIRUS MUTATION;

EID: 0036242257     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2002.32710     Document Type: Article

References (43)

1. Rising incidence of hepatocellular carcinoma in the United States
2. The risk of transfusion-transmitted viral infections
3. The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors
4. Isolation, characterization and biological significance of hepatitis B virus mutants from serum of a patient with immunologically negative HBV infection
5. Occult hepatitis B virus after acute self-limited infection persisting for 30 years without sequence variation
6. Persistence of hepatitis B viral DNA after serological recovery from hepatitis B virus infection
7. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: Clinically significant or purely "occult"?
8. "Occult" hepatitis B virus as source of infection in liver transplant recipients
9. Persistence of hepatitis-B virus DNA in the liver after loss of HBsAg in chronic hepatitis-B
10. Characterization of unusual escape variants of hepatitis B virus isolated from a hepatitis B surface antigen-negative subject
11. Complete nucleotide sequence and viral envelope protein expression of a hepatitis-B virus DNA derived from a hepatitis-B surface antigen-seronegative patient
12. Persistence of hepatitis B virus DNA in serum and liver from patients with chronic hepatitis B after loss of HBsAg
13. Occult hepatitis B virus infection in HBs antigen-negative hepatocellular carcinoma in a Japanese population: Involvement of HBx and p53
14. Transmission of hepatitis B from hepatitis-B-seronegative subjects
15. Transmission of serologically silent hepatitis B virus along with hepatitis C virus in two cases of posttransfusion hepatitis
16. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease
17. Hepatitis C virus is frequently coinfected with serum marker-negative hepatitis B virus: Probable replication promotion of the former by the latter as demonstrated by in vitro cotransfection
18. Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only. Swiss HIV Cohort Study
19. Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: High percentage of carriers of hepatitis B and C virus
20. Hepatitis B virus occult infection in subjects with persistent isolated anti-HBc reactivity
21. Altered antigenicities of hepatitis B virus surface antigen carrying mutations outside the common "a" determinant
22. Reactivity of 13 in vitro expressed hepatitis B surface antigen variants in 7 commercial diagnostic assays
23. High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum
24. A novel deletion mutant of hepatitis B virus surface antigen
25. High incidence of hepatitis B infections among chronic hepatitis cases of unknown aetiology
26. A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients
27. Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli
28. In vitro infection of human hepatoma cells (HepG2) with hepatitis B virus (HBV): Spontaneous selection of a stable HBV surface antigen-producing HepG2 cell line containing integrated HBV DNA sequences
29. Prediction of transmembrane segments in proteins utilising multiple sequence alignments
30. Identification of hepatitis B surface antigen variants with alterations outside the "a" determinant in immunized Singapore infants
31. Point mutation in the S gene of hepatitis B virus for a d/y or w/r subtypic change in two blood donors carrying a surface antigen of compound subtype adry or adwy
32. Mechanism of suppression of hepatitis B virus precore RNA transcription by a frequent double mutation
33. Hepatitis B surface antigen particles with all four subtypic determinants: Point mutations of hepatitis B virus DNA inducing phenotypic changes or double infection with viruses of different subtypes
34. Characterization of the hepatitis B virus major surface antigen promoter hepatocyte nuclear factor 3 binding site
35. High affinity binding site for nuclear factor I next to the hepatitis B virus S gene promoter
36. Activation of the hepatitis B virus S promoter by transcription factor NF-Y via a CCAAT element
37. Regulation of transcription from the hepatitis B virus major surface antigen promoter by the Sp1 transcription factor
38. Differential regulation of the hepatitis B virus surface gene promoters by a second viral enhancer
39. Functions of the large hepatitis B virus surface protein in viral particle morphogenesis
40. Assembly of viral particles in Xenopus oocytes: Pre-surface antigens regulate secretion of the hepatitis B viral surface envelope particle
41. Key role of a CCAAT element in regulating hepatitis B virus surface protein expression
42. The pre-S region determines the intracellular localization and appearance of hepatitis B virus
43. Two control elements in the hepatitis B virus S-promoter are important for full promoter activity mediated by CCAAT-binding factor